No Data
No Data
Gelonghui Announcements Selected | Mindray Healthcare: Net profit increased 22.9% to 3.16 billion yuan in the first quarter, and all three major international business lines achieved rapid growth; Yunnan Baiyao: Net profit of 1.702 billion yuan in the fir
[Performance data] Sanan Optoelectronics (600703.SH): Net profit of 367 million yuan in 2023, and plans to distribute 0.3 yuan Sanan Optoelectronics (600703.SH) to release the 2023 annual report, achieving operating income of 14.53 billion yuan, an increase of 6.28%; net profit attributable to shareholders of listed companies was 367 million yuan, a year-on-year decrease of 46.50%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - $1,088 million, with basic earnings per share of 0.07 yuan. It is proposed to distribute a cash dividend of 0.30 yuan (tax included) for every 10 shares to all shareholders. Changsha silver
Marumi Co., Ltd. (603983.SH): Net profit increased by 48.93% to 259 million yuan in 2023, plans to distribute 10 to 5.2 yuan
On April 26, Ge Longhui Co., Ltd. (603983.SH) released its 2023 annual report, achieving operating income of 2,226 billion yuan, an increase of 28.52%; net profit attributable to shareholders of listed companies of 259 million yuan, an increase of 48.93% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 188 million yuan, an increase of 38.16% year on year; and basic earnings per share of 0.65 yuan. It is proposed that all shareholders receive a cash dividend of 5.20 yuan (tax included) for every 10 shares.
Does This Valuation Of Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Imply Investors Are Overpaying?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Guangdong Marubi Biotechnology fair value estimate is CN¥21.42 Guangdong Marubi Biotechnology's CN¥27.06 share price signals that it might be
Guangdong Marubi Biotechnology (SHSE:603983) Seems To Use Debt Quite Sensibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi
Marumi Co., Ltd. (603983.SH): Obtained a high-tech enterprise certificate
Gelonghui, Feb. 23: Marumei Co., Ltd. (603983.SH) announced that it has received a high-tech enterprise certificate jointly issued by the Guangdong Provincial Department of Science and Technology, the Guangdong Provincial Department of Finance, and the Guangdong Provincial Taxation Bureau of the State Administration of Taxation. The certificate number is GR202344003218; the date of issue is December 28, 2023; it is valid for three years. After being certified as a high-tech enterprise in 2011, 2014, 2017, and 2020, the company was once again certified as a high-tech enterprise. This is a re-certification carried out after the validity of the company's original high-tech enterprise certificate has expired, and it will not be subject to public approval
Marumi Co., Ltd. (603983.SH): Expected net profit increase of 72% to 89% for 2023
Gelonghui, January 22丨Marumei Co., Ltd. (603983.SH) announced its 2023 annual results forecast. According to preliminary estimates by the company's finance department, it is expected to achieve net profit attributable to owners of the parent company in 2023 of 300,000 yuan to 330 million yuan. Compared with the same period last year, it will increase by 125.82 million yuan to 155.82 million yuan, an increase of 72% to 89% over the previous year. Net profit attributable to owners of the parent company after deducting non-recurring profit and loss is expected to be between RMB 220 million and RMB 250 million in 2023, an increase of 8,4 compared with the same period last year
No Data